Clinical details of 50 patients and controls with specific reference to factors known to affect lipids
| Factor | Patient | Control |
| Mean age (years, range) | 44.8 (20–72) | 44.8 (20–72) |
| Sex (M/F) | 21/29 | 21/29 |
| Mean body mass index (SD) | 25.8 (5.6) | 24.6 (4.7) |
| PASI1-150 score (mean, range) | 3.3 (0–8.7) | 0 |
| Subgroup of joint disease (number of patients) | ||
| Oligoarthritis | 21 | 0 |
| Polyarthritis | 27 | 0 |
| Mutilans | 1 | 0 |
| Spondylitis | 1 | 0 |
| History of gout | 0 | 4 |
| Topical dovanex | 1 | 0 |
| NSAIDs1-150 | 48 | 0 |
| Oral contraceptive | 0 | 5 |
| Hormone replacement therapy | 0 | 7 |
| Antihypertensive drugs | ||
| β Blockers | 1 | 1 |
| Thiazides | 1 | 1 |
No patient or control had concurrent infection, malignancy, ischaemic heart disease, liver disease or was taking corticosteroids or retinoids.
↵1-150 PASI = psoriasis area and severity index; NSAIDs = non-steroidal anti-inflammatory drugs.